Showing results (301-310 of 370) with videos related to
Sort By:
Pageof 37
Annals of Clinical and Laboratory Science|January 1, 1983
Clinical application of the clonogenic assayD H Kern, C A Bertelsen, B D Mann, et al.Surgery|November 1, 1978
The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary studyH J Fee, D S Robinson, W F Sample, et al.Archives of Surgery (Chicago, Ill. : 1960)|October 1, 1976
Immunology and adjuvant chemoimmunotherapy of breast cancerF C Sparks, A G Wile, K P Ramming, et al.International Journal of Cancer|January 14, 1998
Ratio of IgG:IgM antibodies to sialyl Lewis(x) and GM3 correlates with tumor growth after immunization with melanoma-cell vaccine with different adjuvants in miceM H Ravindranath, M C Kelley, R C Jones, et al.International Journal of Cancer|April 15, 1976
Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effectsH L Sulit, S H Golub, R F Irie, et al.American Journal of Surgery|July 1, 1980
Pulmonary resection for metastatic sarcomaJ F Huth, E C Holmes, S E Vernon, et al.Surgery|August 1, 1983
Natural thermal resistance of human tumor cells and the role of prostaglandinF K Storm, D J Roe, S Hildebrand-Zanki, et al.International Journal of Dermatology|June 1, 1981
Melanoma. Associated antigens in benign melanocytic disordersJ N Fox, K M Sheikh, R K Gupta, et al.Cancer Research|July 1, 1994
Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune responseA Barth, D S Hoon, L J Foshag, et al.Cancer|October 8, 1998
Tumor-associated antigen TA-90 immune complex assay predicts subclinical metastasis and survival for patients with early stage melanomaM C Kelley, R C Jones, R K Gupta, et al.Pageof 37